Table 1.

Patient demographics and baseline characteristics

CharacteristicsStudy Population (N = 22)
Age, year (median, range)55 (21–69)
Gender, N (%)
 Male11 (50)
 Female11 (50)
Race, N (%)
 White13 (59)
 Black5 (23)
 Asian1 (4)
 Other3 (14)
Tumor type, N (%)
 Lung cancer11 (50)
 Squamous cell head and neck cancer2 (9)
 Endocrine cancer2 (9)
 Sarcoma2 (9)
 Colorectal cancer2 (9)
 Gastro/esophageal cancer2 (9)
 Breast cancer1 (5)
Prior chemotherapy
 Platinum-containing regimen, N (%)11 (50)
 Prior lines of therapyMean: 2.5 (1 = 12; 2 = 2; ≥3 = 8)
NC-6004 dose level (mg/m2), N (%)
 601 (5)
 751 (5)
 901 (5)
 1051 (5)
 1201 (5)
 1359 (41)
 1506 (27)
 1651 (5)
 1801 (5)